Valiant Pharmaceuticals Private Limited
About Valiant Pharmaceuticals Private Limited
Data last updated:
Valiant Pharmaceuticals Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U85200UP2016PTC084261. Its GSTIN is 09AAFCV5329K1ZV (Uttar Pradesh).
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manish Trivedi and Shiva Dutt Trivedi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 824/914 A Damodar Nagar Barra, Kanpur, Uttar Pradesh, India – 208027.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.78 Lakh, a growth of 84% compared to the previous year. For the same year it recorded a net profit of ₹29,255 (net margin 7.7%) and EBITDA of ₹29,255 (EBITDA margin 7.7%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address824/914 A Damodar Nagar Barra, Kanpur, Uttar Pradesh, India – 208027
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Valiant Pharmaceuticals Private Limited
The main business activity of Valiant Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Valiant Pharmaceuticals Private Limited FY 2024 filings available
Valiant Pharmaceuticals Private Limited reported revenue of ₹3.78 Lakh (up 84% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Valiant Pharmaceuticals Private Limited
Revenue rose 84% in the latest year. EBITDA rose 848% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Valiant Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹29,255 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹29,255 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Valiant Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Valiant Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Valiant Pharmaceuticals Private Limited
Valiant Pharmaceuticals Private Limited is audited by V. PANDEY ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V. PANDEY ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Valiant Pharmaceuticals Private Limited
Valiant Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shiva Dutt Trivedi | Additional Director | 13 Sep 2019 | 7 Years 0 Months | Current |
| Manish Trivedi | Director | 22 Jun 2016 | 10 Years 3 Months | Current |
Ownership and Shareholding of Valiant Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Valiant Pharmaceuticals Private Limited
Valiant Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Valiant Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Valiant Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Valiant Pharmaceuticals Private Limited
Valiant Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Prashant Kumar ceased to be Director on 13 Sep 2019.
Credit Ratings, Litigation & Regulatory Alerts for Valiant Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Valiant Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Valiant Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Valiant Pharmaceuticals Private Limited
Valiant Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCV5329K1ZV | Uttar Pradesh | Active | 27 Jul 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Valiant Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Valiant Pharmaceuticals Private Limited
Valiant Pharmaceuticals is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 June 2016 (10+ years old) and is registered under CIN U85200UP2016PTC084261.
Valiant Pharmaceuticals reported revenue of ₹3.78 Lakh for FY 2024 (up 84% YoY).
Valiant Pharmaceuticals has 2 current directors:
- Shiva Dutt Trivedi - Additional Director
- Manish Trivedi - Director
Valiant Pharmaceuticals reported a net profit of ₹29,255 (net margin 7.7%) and EBITDA of ₹29,255 (EBITDA margin 7.7%) for FY 2024, as per its filed financial statements.
The GSTIN of Valiant Pharmaceuticals is 09AAFCV5329K1ZV, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Valiant Pharmaceuticals is U85200UP2016PTC084261. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Valiant Pharmaceuticals was incorporated on 22 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
Prashant Kumar ceased to be Director on 13 Sep 2019. Shiva Dutt Trivedi was appointed as Additional Director on 13 Sep 2019. Manish Trivedi was appointed as Director on 22 Jun 2016.
The registered office of Valiant Pharmaceuticals is at 824914 A Damodar Nagar Barra, Kanpur, Uttar Pradesh, India – 208027.
Valiant Pharmaceuticals has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹1 Lakh.